# Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE)

> **NCT06029244** · NA · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 160 (actual)

## Conditions studied

- Delirium
- Delirium in Old Age
- Critical Illness
- Intensive Care Unit Delirium

## Interventions

- **DEVICE:** EyeControl-Pro
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT06029244
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-25
- **Primary completion:** 2025-10-20
- **Final completion:** 2025-11-18
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-12-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06029244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06029244, "Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06029244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*